Welcome to the world of cosmetics, where labelling compliance is the key to unlocking market…
Welcome to the world of cosmetics, where labelling compliance is the key to unlocking market…
In the ever-evolving cosmetics industry, achieving compliance with regulations is paramount. However, juggling multiple regulations…
As an IVD (In Vitro Diagnostic) Korean manufacturer, accessing the EU (European Union) market can…
Most in vitro diagnostic medical devices require the involvement of a notified body or approved…
Introducing new restrictions for Butylated Hydroxytoluene (BHT) and Acid Yellow 3 in cosmetic products, the Commission Regulation (EU) 2022/2195 brings changes to the industry
MoCRA deadlines you need to keep in mind when selling cosmetic products in the U.S
Obelis Wins a Second Trends Gazelle Award.Growing from Medium-Sized to Big Enterprises CategoryWant to know more? Visit our page!
We are thrilled to announce that Obelis Group has been chosen as one of the regulatory consultants for the Luxemburgish Ministry of Economy’s Fit 4 Innovation
To prevent market disruptions and give manufacturers enough time to certify their medical devices under…
The EU proposal aims to introduce new hazard classes based on scientific criteria for endocrine disruptors as well as other chemicals which can accumulate in living organisms or enter the water cycle.